Tech Company Financing Transactions
Neon Therapeutics Funding Round
Neon Therapeutics closed a $55 million Series A funding round on 10/2/2015. Backers included Access Industries, Clal Biotechnology Industries and Third Rock Ventures.
Transaction Overview
Company Name
Announced On
10/2/2015
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series A
Proceeds Purpose
The contributions from world-leading experts in core scientific advances in neoantigen biology have paved the way for the founding of Neon Therapeutics, and the company plans to work closely with them moving forward to bring new therapies to patients.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
40 Erie St. 110
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
We have assembled a team of world experts in cancer immunotherapy to develop therapies that target abnormal proteins called neoantigens, which are produced by cancer cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Cary Pfeffer
Chief Executive Officer
Hugh O'Dowd
Chief Financial Officer
Yasir Al-Wakeel
VP - Bus. Development
Robert Ang
VP - Human Resources
Teresa Regan
VP - Product Management
Kelledy Manson
VP - R & D
Richard Gaynor
Browse more venture capital transactions:
Prev: 10/2/2015: Elcelyx Therapeutics venture capital transaction
Next: 10/2/2015: Spiral Genetics venture capital transaction
Share this article
About Database of VC Transactions
We report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs